Gowling WLG

Principal Associate

Christopher Freeth is a Principal Associate in the Intellectual Property team and advises clients across a range of contentious and non-contentious matters, with a particular focus on patent litigation in the life science sector. Christopher's litigation experience spans a range of products and areas, including leading on an appeal concerning plausibility of unconventional medical techniques in the High Court, groundless threats in the IPEC, inventor-ship of a well-known over-the-counter painkiller in the IPO, and advising on other confidential issues and strategy for clients involved in areas such as antibody production and genetic engineering. He routinely advises clients at the pre-litigation stage too and has a particularly strength in producing clear and comprehensive opinions on patents to guide you on your best options and where your business might stand in any future dispute.